Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Lyrica
Generic name / active ingredient
pregabalin
Dosage-form class
Oral capsules 25/50/75/100/150/200/225/300 mg; oral solution 20 mg/mL(as documented in this record)
Route
Oral
Record reviewed
2026-08-21

Copy from the pack in hand

Source-linked reading points

  • Check LYRICA, pregabalin, capsule or oral solution, stated strength and target market together. Capsule mg and oral-solution concentration are not an answer that can be self-converted into a number of capsules or millilitres; confirm from the actual prescription and product label.
  • This FDA label lists effects such as dizziness and somnolence for attention and flags combinations with other central-nervous-system depressants for extra review. With older age, falls, alcohol, or sleep, sedative or pain medicines, bring the full medicine list to a pharmacist or clinician.
  • The label also warns against self-directed abrupt discontinuation. Any taper, stop, or conversion between capsule and oral solution needs a plan from the prescribing team for the exact product and condition, not a webpage or package photo.

Reviewed presentation examples — compare every field

  • Pregabalin 25 mg per capsule; 90-capsule bottleNDC 58151-236-77
  • Pregabalin 50 mg per capsule; 90-capsule bottleNDC 58151-237-77
  • Pregabalin 75 mg per capsule; 90-capsule bottleNDC 58151-238-77
  • Pregabalin 100 mg per capsule; 90-capsule bottleNDC 58151-239-77
  • Pregabalin 150 mg per capsule; 90-capsule bottleNDC 58151-240-77
  • Pregabalin 200 mg per capsule; 90-capsule bottleNDC 58151-241-77
  • Pregabalin 225 mg per capsule; 90-capsule bottleNDC 58151-243-77
  • Pregabalin 300 mg per capsule; 90-capsule bottleNDC 58151-242-77

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-21
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image